Inmode ( (INMD) ) has released its Q2 earnings. Here is a breakdown of the information Inmode presented to its investors.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
InMode Ltd. is a global leader in innovative medical technologies, specializing in the development and marketing of devices utilizing novel radio frequency technology for various medical fields including plastic surgery and dermatology. In its second quarter of 2025 financial results, InMode reported a revenue increase to $95.6 million, maintaining an 80% gross margin, despite challenges in the U.S. market. The company saw a slight decline in consumables and service revenues but achieved a GAAP net income of $26.7 million, up from $23.8 million in the previous year. InMode’s international sales, particularly in Europe, reached record highs, providing a buffer against domestic economic challenges. The company holds a strong cash position of $510.7 million, which supports its strategic initiatives and global expansion. Looking ahead, InMode’s management remains focused on navigating macroeconomic uncertainties and sustaining long-term growth, with adjusted revenue projections for 2025 between $365 to $375 million.